This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
. “The past few years have shown us that there is still work to be done for the chronic condition managementindustry to improve the lives of patients globally. a chronic painmanagement and virtual care company, where he directed partnerships, clinical trials, regulatory submissions, hiring and expansion across North America.
The rapid growth of digital health and the potential for disruption in the healthcare industry made it an attractive investment proposition. However, as with any early-stage biotech company, there's inherent risk involved, and their long-term success hinges on the successful development and commercialization of their drugs.
By the end of the year we will see the use of Virtual Assistants by patients to help interact with their health data and "transact" via voice technology to order repeat prescriptions, painmanagement and medication requests. Voice technology also has massive potential for clinical drug trials. link] [link]
The rapid growth of digital health and the potential for disruption in the healthcare industry made it an attractive investment proposition. However, as with any early-stage biotech company, there's inherent risk involved, and their long-term success hinges on the successful development and commercialization of their drugs.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content